Publications by Medical Specialty - Oncology

These publications were authored or co-authored by Quest Diagnostics staff.

SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours.

Authors: Hoskoppal D, Epstein JI, Gown AM, Arnold Egloff SA, Gordetsky JB, Shi CJ, Giannico GA.
Histopathology. 2020 Mar;76:550-559. doi: 10.1111/his.14012. Epub 2020 Jan 24.

Specialties: Oncology

Disclaimer: One or more of the authors of this publication were employed at the time by , a subsidiary of Quest Diagnostics.

Salivary ghost cell carcinoma: case report and proposal of a new entity.

Authors: Ihrler S, Mollenhauer M, Weitmayr B, Haas CJ.
Virchows Arch. 2020 Mar;476(3):465-468.

Specialties: Dermatology, Oncology

Disclaimer: One or more of the authors of this publication were employed at the time by DermPath, a subsidiary of Quest Diagnostics.

Development and Validation of a 34-Gene Inherited Cancer Predisposition Panel Using Next-Generation Sequencing

Authors: Rosenthal SH, Sun W, Zhang K, Liu Y, Nguyen Q, Gerasimova A, Nery C, Cheng L, Castonguay C, Hiller E, Li J, Elzinga C, Wolfson D, Smolgovsky A, Chen R, Buller-Burckle A, Catanese J, Grupe A, Lacbawan F,Owen R
BioMed Res Int. 2020, https://doi.org/10.1155/2020/3289023 [Epub ahead of print]

Specialties: Oncology

Read the Key Summary (Download PDF)

Immunotherapy- (Blinatumomab-) Related Lineage Switch of KMT2A/AFF1 Rearranged B-Lymphoblastic Leukemia into Acute Myeloid Leukemia/Myeloid Sarcoma and Subsequently into B/Myeloid Mixed Phenotype Acute Leukemia.

Authors: He RR, Nayer Z, Hogan M, Cuevo RS, Woodward K, Heyer D, Curtis CA, Peterson JF.
Case Rep Hematol. 2019 Dec 7;2019:7394619.

Specialties: Oncology

Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia.

Authors: Shmukler BE, Rivera A, Bhargava P, Nishimura K, Kim EH, Hsu A, Wohlgemuth JG, Morton J, Snyder LM, De Franceschi L, Rust MB, Hubner CA, Brugnara C, Alper SL.
Blood Cells Mol Dis. 2019 Nov 25;81:102389.

Specialties: Oncology

SATB2 Protein Expression by Immunohistochemistry is a Sensitive and Specific Marker of Appendiceal and Rectosigmoid Well Differentiated Neuroendocrine Tumors.

Authors: Hoskoppal D, Epstein JI, Gown AM, Arnold Egloff SA, Gordetsky J, Shi CC, Giannico GA.
Histopathology. 2019 Oct 9. doi: 10.1111/his.14012. [Epub ahead of print]

Specialties: Oncology

Quantitative assessment of PD-L1 as an analyte in immunohistochemistry diagnostic assays using a standardized cell line tissue microarray

Authors: Martinez-Morilla S, McGuire J, Gaule P, Moore L, Acs B, Cougot D, Gown AM, Yaziji H, Wang WL, Cartun RW, Hornick JL, Sholl LM, Qiu J, Mino-Kenudson M, Yi ES, Beasley MB, Merrick DT, Ambaye AB, Zhang ZJ, Walker J, Rimm DL.
Lab Invest. 2020 Jan;100:4-15. Epub 2019 Aug 13

Specialties: Oncology

Pancreatic neuroendocrine microadenomatosis presenting as a functional VIPoma.

Authors: Krainev AA, Mathavan VK, Klink DF, Saxe JM, Ong GKB, Murphy JK.
J Surg Case Rep. 2019 Jun 28;2019(6):rjz196.

Specialties: Dermatology, Endocrinology, Diabetes & Metabolism, Gastroenterology, Oncology

Disclaimer: One or more of the authors of this publication were employed at the time by AmeriPath, a subsidiary of Quest Diagnostics.

Therapeutic plasma exchange for management of heparin-induced thrombocytopenia: Results of an international practice survey.

Authors: Onwuemene OA, Zantek ND, Rollins-Raval MA, Raval JS, Kiss JE, Ipe TS, Kuchibhatla M, Pagano MB, Wong ECC
J Clin Apher 2019 May 22. doi: 10.1002/jca.21709. [Epub ahead of print]

Specialties: Hematology/Hemostasis/Thrombosis, Oncology

Multiple immune suppressive mechanisms in fibrolamellar carcinoma.

Authors: Kim AK, Gani F, Layman AJ, Besharati S, Zhu Q, Succaria F, Engle EL, Bhaijee F, Goggins MB, Llosa NJ, Pawlik TM, Yarchoan M, Jaffee EM, Simons HC, Taube JM, Anders R.
Cancer Immunol Res. 2019 Mar;doi: 10.1158/2326-6066.CIR-18-0499. [Epub ahead of print]

Specialties: Dermatology, Gastroenterology, Oncology

Disclaimer: One or more of the authors of this publication were employed at the time by AmeriPath, a subsidiary of Quest Diagnostics.